CytomX Therapeutics, Inc. (CTMX)
NASDAQ: CTMX · Real-Time Price · USD
2.040
0.00 (0.00%)
At close: Nov 13, 2026, 4:00 PM EST
2.040
0.00 (0.00%)
Pre-market: Nov 16, 2026, 4:03 AM EST
CTMX's stock price has decreased by -51.77% in the past year and price targets may not have had time to catch up.
CytomX Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| J.P. Morgan | J.P. Morgan | Buy Maintains $11 → $12 | Buy | Maintains | $11 → $12 | +488.24% | Nov 12, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $12 | Buy | Maintains | $12 | +488.24% | Nov 6, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $12 | Buy | Reiterates | $12 | +488.24% | Nov 6, 2026 |
| Guggenheim | Guggenheim | Buy Maintains $14 | Buy | Maintains | $14 | +586.27% | Nov 6, 2026 |
| Wedbush | Wedbush | Buy Maintains $11 → $12 | Buy | Maintains | $11 → $12 | +488.24% | Nov 6, 2026 |
| Barclays | Barclays | Buy Maintains $16 | Buy | Maintains | $16 | +684.31% | Nov 6, 2026 |
| Wolfe Research | Wolfe Research | Buy Initiates $6 | Buy | Initiates | $6 | +194.12% | May 19, 2026 |